Skip to content
About Us
Services
Success Stories
Publications
Research
Events
Online Programs
About Us
Services
Success Stories
Publications
Research
Events
Online Programs
Login
₱
0.00
0
Cart
₱
0.00
0
Cart
Understanding Pneumonia:
Trends, Prevention, and the Role of Pharmacists
ASSESMENT TEST
Assessment Unilab
"
*
" indicates required fields
Name
First
Last
Email
1. What is the topic of the Round Table Discussion?
*
a. Cefpodoxime an effective treatment for Respiratory Tract Infections
b. Cefpodoxime in Respiratory Tract Infections
c. Cefpodoxime in the Management of Respiratory Tract Infections
2. Cefpodoxime is a ____________generation Cephalosporin.
*
a. 1st generation
b. 2nd generation
c. 3rd generation
3. Cefpodoxime is a potent antibiotic active against a variety of gram _______ and negative bacteria.
*
positive
negative
none
4. All are indicated for Cefpodoxime EXCEPT:
*
a. Community Acquired Pneumonia
b. Pharyngitis/Tonsillitis
c. GERD
5. What is the dosage of Cefpodoxime?
a. 6mg/kg/day
b. 10mg/kg/day
c. 5mg/kg/day
6. ______________ is an inflammatory condition of the pharyngeal wall, often divided into pharyngitis and tonsillitis.
*
a. Otitis Media
b. Community-acquired Pneumonia
c. Acute Pharyngotonsillitis
7. The most common and important bacterial cause of pharyngitis is __________ (group A Streptococcus [GAS])
*
a. Streptococcus pyogenes
b. Streptococcus pneumoniae
c. Streptococcus aureus
8. True or False: Cefpodoxime offers antimicrobial spectrum similar to Ceftriaxone.
*
True
False
9. True or False: Cefpodoxime can be considered as an appropriate choice for the empirical treatment where there is emerging resistance to traditional antimicrobial therapy.3
*
True
False
10. True or False: Cefpodoxime is an orally, semi-synthetic, third generation cephalosporin.1
*
True
False
About Us
Services
Success Stories
Publications
Research
Events
Online Programs
About Us
Services
Success Stories
Publications
Research
Events
Online Programs